Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy & Safety of Piroxicam Plus Counterirritant Gel Compared With Other Topical Non-Steroid Anti-Inflammatory Drugs in Managing Musculoskeletal Pain: A Randomized Clinical Study

NCT07475663 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Indonesia as lead sponsor.

NCT NCT07475663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07475663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy & Safety of Piroxicam Plus Counterirritant Gel Compared With Other Topical Non-Steroid Anti-Inflammatory Drugs in Managing Musculoskeletal Pain: A Randomized Clinical Study
Lead sponsor
Taisho Pharmaceutical Indonesia
Phase
Phase 3
Overall status
Completed
Start date
November 4, 2025
Completion date
February 12, 2026
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankle sprain, back pain, osteoarthritis (oa) of the knee, runner's knee, tennis elbow